Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas G Cost

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
The Journal of Urology|November 29, 2022
Pediatric Small Renal Masses: Can Tumor Size Predict Histology and the Potential for Nephron-sparing Surgery?Daniel S Han, Jonathan P Walker, Andrew Nicklawsky, et al.
Cancer Cell|December 18, 2014
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinomaDaniel P Hall, Nicholas G Cost, Shailaja Hegde, et al.
Journal of Pediatric Surgery|June 22, 2025
What Every Pediatric Surgeon Should Know About Common Systemic Therapies for the Treatment of Renal Tumors in Children and AdolescentsAlicia D Menchaca, Shachi Srivatsa, Kathleen Kieran, et al.
Cancer|June 16, 2018
The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testingMariana M Cajaiba, Lisa M Dyer, James I Geller, et al.
The Journal of Pediatrics|May 21, 2023
Disparate Access to Fertility Preservation in Youth: A Call for Advocacy to Close the GapKristin E Canavera, Kari L Bjornard, Nicholas G Cost, et al.
Cancer|September 14, 2020
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 studyJames I Geller, Nicholas G Cost, Yueh-Yun Chi, et al.
European Urology|March 4, 2011
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombusNicholas G Cost, Scott E Delacroix, Joshua P Sleeper, et al.
Gynecologic Oncology|October 18, 2017
DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor RegistryKris Ann P Schultz, Anne K Harris, Michael Finch, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Journal of the American College of Surgeons|January 22, 2024
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2Harold N Lovvorn, Lindsay A Renfro, Daniel J Benedetti, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
The Journal of Urology|November 29, 2022
Pediatric Small Renal Masses: Can Tumor Size Predict Histology and the Potential for Nephron-sparing Surgery?Daniel S Han, Jonathan P Walker, Andrew Nicklawsky, et al.
Cancer Cell|December 18, 2014
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinomaDaniel P Hall, Nicholas G Cost, Shailaja Hegde, et al.
Journal of Pediatric Surgery|June 22, 2025
What Every Pediatric Surgeon Should Know About Common Systemic Therapies for the Treatment of Renal Tumors in Children and AdolescentsAlicia D Menchaca, Shachi Srivatsa, Kathleen Kieran, et al.
Cancer|June 16, 2018
The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testingMariana M Cajaiba, Lisa M Dyer, James I Geller, et al.
The Journal of Pediatrics|May 21, 2023
Disparate Access to Fertility Preservation in Youth: A Call for Advocacy to Close the GapKristin E Canavera, Kari L Bjornard, Nicholas G Cost, et al.
Cancer|September 14, 2020
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 studyJames I Geller, Nicholas G Cost, Yueh-Yun Chi, et al.
European Urology|March 4, 2011
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombusNicholas G Cost, Scott E Delacroix, Joshua P Sleeper, et al.
Gynecologic Oncology|October 18, 2017
DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor RegistryKris Ann P Schultz, Anne K Harris, Michael Finch, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Journal of the American College of Surgeons|January 22, 2024
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2Harold N Lovvorn, Lindsay A Renfro, Daniel J Benedetti, et al.
Pageof 16